Advertisement
Screener

Harrow, Inc. (HROW) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

Harrow, Inc. Cash Flow Breakdown

Cash flow breakdown shows where Harrow, Inc.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $43.86M came in.
  • Fiscal year ended 2025-12-31: from investing, $5.46M went out.
  • Fiscal year ended 2025-12-31: from financing, $12.72M went out.
  • Fiscal year ended 2025-12-31: change in cash, $25.68M came in.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingBuybacksDebt paid backNew debtNew shares soldNot split outChange in cash
2025-12-31$43.86M-$5.46M-$230.90M$244.38M$467.00K-$26.66M*$25.68M
2024-12-31-$22.20M-$33.16M$29.78M$1.11M-$2.36M*-$26.84M
2023-12-31$3.84M-$152.55M-$59.75M$55.88M$64.52M$65.88M*-$22.18M
2022-12-31$1.71M-$1.74M$22.66M$31.49M*$54.10M
2021-12-31$5.08M-$18.69M$65.00K$51.41M*$37.87M
2020-12-31-$1.10M-$981.00K$1.43M*-$648.00K
2019-12-31$950.00K-$1.83M-$1.01M*-$1.89M
2018-12-31$687.00K-$2.20M$642.00K$3.49M*$2.62M
2017-12-31-$8.80M-$961.00K$1.12M$3.81M*-$4.83M
2016-12-31-$11.21M-$7.29M$212.00K$24.46M*$6.17M
2015-12-31-$11.14M-$5.13M$404.00K$10.34M*-$5.53M
2014-12-31-$7.06M-$910.00K$13.00K$586.00K*-$7.37M
2013-12-31-$4.44M-$70.00K-$191.00$10.05M$5.54M
2012-12-31-$1.90M-$15.49K$11.50M$9.89M
2011-12-31-$291.16K$0.00$0.00-$145.30K
2010-12-31-$2.30M$0.00$1.00M*-$1.30M

Each quarter (3 month)

Quarter endRunning the businessFrom investingBuybacksDebt paid backNew debtNew shares soldNot split outChange in cash
2026-06-30-$9.76M*-$534.00K*$811.00K*
2026-03-31-$8.99M-$18.20M$25.00K$48.89M*$21.72M
2025-12-31$8.41M*-$4.73M*$180.00K*-$5.22M*
2025-09-30$16.59M*-$225.00K*$162.00K*$4.80M*
2025-06-30-$803.00K*-$293.00K*$102.00K*-$12.77M*
2025-03-31$19.67M-$212.00K$23.00K$19.48M
2024-12-31-$17.78M*-$37.56M*$105.00K*$29.88M*
2024-09-30$2.95M*-$597.00K*$484.00K*-$1.21M*
2024-06-30-$2.75M*$5.10M*$173.00K*
2024-03-31-$4.63M-$110.00K$348.00K-$1.16M*-$5.55M
2023-12-31$8.70M*-$203.00K*$0.00*$0.00*$24.00K*
2023-09-30-$1.21M*-$20.13M*$0.00*$0.00*$18.00K*$64.18M*
2023-06-30$4.57M*-$1.25M*$0.00*$0.00*$189.00K*
2023-03-31-$8.21M-$130.97M-$59.75M$55.88M$148.00K$65.89M*-$77.02M
2022-12-31-$3.71M*-$5.00K*$635.00K*$54.39M*
2022-09-30-$410.00K*-$1.07M*$0.00*
2022-06-30$4.86M*-$259.00K*$3.00K*
2022-03-31$967.00K-$410.00K$4.00K-$780.00K*-$219.00K
2021-12-31-$1.49M*-$14.20M*$0.00*
2021-09-30-$2.08M*-$12.93M*$17.00K*
2021-06-30$5.44M*$8.67M*$52.24M*
2021-03-31$3.21M-$224.00K-$781.00K*$2.20M
2020-12-31-$566.00K*-$90.00K*-$770.00K*
2020-09-30$2.67M*-$281.00K*-$761.00K*
2020-06-30-$2.65M*-$337.00K*$2.97M*
2020-03-31-$550.00K-$273.00K-$825.00K
2019-12-31$1.65M*-$969.00K*$635.00K*
2019-09-30-$70.00K*-$79.00K*
2019-06-30$844.00K*-$461.00K*
2019-03-31-$1.48M-$324.00K-$773.00K*-$2.57M
2018-12-31-$36.00K*-$852.00K*$0.00*$1.41M*
2018-09-30$323.00K*-$647.00K*$1.00K*$2.47M*$2.15M*
2018-06-30$1.36M*-$436.00K*$519.00K*$1.28M*
2018-03-31-$965.00K-$264.00K$122.00K-$1.33M
2017-12-31-$294.00K*-$249.00K*$962.00K*$152.00K*
2017-09-30-$2.22M*-$197.00K*$2.12M*-$298.00K*
2017-06-30-$2.31M*-$299.00K*-$627.00K*-$3.23M*
2017-03-31-$3.98M-$216.00K$2.74M*-$1.46M
2016-12-31-$2.24M*-$164.00K*$17.00K*$8.88M*$6.49M*
2016-09-30-$3.91M*-$1.15M*$1.98M*-$3.08M*
2016-06-30-$2.77M*-$3.56M*-$6.38M*
2016-03-31-$2.30M-$2.42M$13.86M*$9.14M
2015-12-31-$3.30M*-$871.00K*$0.00*-$3.87M*
2015-09-30-$2.40M*-$1.05M*$0.00*-$3.50M*
2015-06-30-$3.17M*-$180.00K*$1.17M*$9.33M*$7.15M*
2015-03-31-$2.27M-$3.03M-$5.31M
2014-12-31-$2.05M*-$82.00K*-$2.15M*
2014-09-30-$1.79M*-$77.00K*-$1.74M*
2014-06-30-$1.53M*-$700.00K*-$2.10M*
2014-03-31-$1.68M-$51.00K-$1.38M
2013-12-31-$1.24M*-$9.52K*$0.00*$0.00*-$1.25M*
2013-09-30-$1.14M*-$5.31K*$1.00*$0.00*-$1.14M*
2013-06-30-$1.00M*-$3.72K*$0.00*$0.00*-$1.01M*
2013-03-31-$1.06M-$51.45K-$192.00$10.05M$8.94M
2012-12-31-$613.71K*-$184.00*-$342.16K*-$955.26K*
2012-09-30-$669.72K*$0.00*$3.94M*$3.27M*
2012-06-30-$282.56K*-$701.00*$7.90M*$7.57M*
2012-03-31-$334.84K-$14.61K$0.00$551.00
2011-12-31$25.68K*$0.00*$144.01K*
2011-09-30-$30.94K*$0.00*-$3.40K*
2011-06-30-$65.31K*$0.00*-$65.31K*
2011-03-31-$220.60K$0.00-$220.60K
2010-12-31-$175.82K*$0.00*-$175.82K*
2010-09-30-$575.34K*$0.00*-$575.34K*

Similar stocks

Stock NameCountryMarket CapPE Ratio
Damora Therapeutics, Inc. (DMRA)$1.250B-6.10
OPKO HEALTH, INC. (OPK)United States$1.220B-15.59
LB PHARMACEUTICALS INC (LBRX)United States$1.220B-10.87
Avalyn Pharma Inc. (AVLN)United States$1.267B
First Tracks Biotherapeutics, Inc. (TRAX)United States$1.280B
Jaguar Health, Inc. (JAGX)United States$1.184B
Latigo Biotherapeutics, Inc. (LTGO)United States$1.176B
Bicara Therapeutics Inc. (BCAX)United States$1.309B-10.55
Tyra Biosciences, Inc. (TYRA)United States$1.337B-12.83
Kardigan, Inc. (KARD)United States$1.346B